Hepatitis C Virus Infection in Dialysis: An Emerging Clinical Reality

Choo Q.L. , Kuo G. , Weiner A.J. , Overby L.R. , Bradley D.W. , Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989; 244: 359–61.

Kuo G. , Choo Q.L. , Alter H.J. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4.

Zeldis J.B. , Depner T.A. , Kuramoto I.K. , Gish R.G. , Holland P.V. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 1990; 112: 958–60.

Getzug T. , Lindsay K. , Brezina M. , Gitnick G. Hepatitis C virus antibody in hemodialysis patients: prevalence and risk factors (letter). Lancet 1990; 335: 589.

Carrera F. , Silva J.G. , Pires C. , Oliveira C. Prevalence of non-A, non-B hepatitis and anti-HCV antibodies in a Portoguese dialysis population. Nephrol Dial Transplant 1992; 7: 913–16.

Fabrizi F. , Raffaele L. , Bacchini G. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic hemodialysis patients. A study with second-generation assays. Nephrol Dial Transplant 1993; 8: 744–7.

Fabrizi F. , Lunghi G. , Andrulli S. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12: 1394–8.

Knudsen F. , Wantzin P. , Rasmussen K. Hepatitis in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993; 43: 1353–6.

Oguchi H. , Miyasaka H. , Tokunaga S. Hepatitis virus infection (HBV and HCV) in chronic Japanese hemodialysis units. Clin Nephrol 1992; 38: 36–43.

Hardy N.M. , Sandroni S. , Danielson S. , Wilson D.J. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992; 38: 44–8.

Jadoul M. , Cornu C. van Ypersele de Strihou, and the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 1993; 44: 1322–6.

Jeffers L.J. , Perez O.G. , de Medina M.D. Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990; 38: 318–22.

Blackmore T.K. , Maddocks P. , Staw N.H. , Hatfield P. Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy and in the staff caring for them. Aust NZ J Med 1992; 22: 352–7.

Hayashi J. , Nakashima K. , Kaijama W. Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol 1991; 134: 651–7

Lin D.Y. , Lin H.H. , Huang C.C. , Liaw Y.F. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993; 21: 288–91.

Chan T.M. , Lok A.S.F. , Cheng J.K.P. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 944–7.

Selgas R. , Martinez-Zapico R. , Bajo M.A. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Perit Dial Int 1992; 12: 28–30.

Mondelli M.U. , Cristina G. , Piazza V. , Cerino A. , Villa G. , Salvadeo A. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay. Nephron 1992; 61: 350–1.

Lin H.H. , Huang C.C. , Sheen I.S. , Lin D.Y. , Liaw Y.F. Prevalence of antibodies to hepatitis C virus in the hemodialysis units. Am J Nephrol 1991; 11: 192–4.

Muller G.Y. , Zabaleta M.E. , Arminio A. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992; 41: 1055–8.

Sheu J.C. , Lee S.H. , Wang J.T. , Shih L.N. , Wang T.H. , Chen D.S. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992; 37: 108–12.

Niu M.T. , Coleman P.J. , Alter M.J. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis 1993; 22: 568–73.

Hassan A.A. , Khalil R. Hepatitis C in dialysis patients in Egypt: relationship to dialysis duration, blood transfusions, and liver disease (letter). Saudi J Kidney Dis Transplant 2000; 11: 72–5.

Huraib S. , al-Rashed R. , Aldrees A. , Aljefry M. , Arif M. , al-Faleh F.A. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: A need for new dialysis strategies. Nephrol Dial Transplant 1995; 10: 470–74.

McIntyre P.G. , Mc Cruden E.A. Hepatitis C virus infection in renal dialysis patients in Glasgow. Nephrol Dial Transplant 1994; 9: 291–5.

Pinto dos Santos J. , Loureiro A. , Cendoroglo Neto M. , Pereira B.J.G. Impact of dialysis room and reuse strategies on the incidence of HCV infection in dialysis units. Nephrol Dial Transplant 1996; 11: 2017–22.

Medici G. , Depetri G.C. , Mileti M. Anti-hepatitis C virus positivity and clinical correlations in hemodialyzed patients. Nephron 1992; 61: 363–4.

Huang C.C. , Wu M.S. , Lin D.Y. , Liaw Y.F. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 31–3.

Barril G. , Traver J.A. Prevalence of hepatitis C virus in dialysis patients in Spain. Nephrol Dial Transplant 1995; 10(suppl. 6): 78–80.

Da Porto A. , Adami A. , Susanna F. Hepatitis C virus in dialysis units: A multicenter study. Nephron 1992; 61: 309–10.

Tokars J.I. , Miller E.R. , Alter M.J. , Arduino M.J. National surveillance of dialysis-associated diseases in the United States, 1997. Semin Dial 2000; 13: 75–85.

Limido A. , Conte F. , Malberti F. , Spotti D. , Marcelli D. , Locatelli F. Prevention of hepatitis B (HBV) and C (HCV) in Lombardy: data from Regional Dialysis and Transplant Registry (RLDT). ERA-EDTA Abstracts 2000; 150.

Tong M.J. , El-Farra N.S. , Reikes A.R. , Co R.L. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463–6.

Niederau C. , Lange S. , Heintges T. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998; 28: 1687–95.

Seef L.B. , Buskell-Bales Z. , Wright E.C. and the National Heart, Lung and Blood Institute Group. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 1906–11.

Kiyosawa K. , Sodeyama T. , Tanaka E. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671–5.

Seef L.B. , Miller R.N. , Rabkin C.S. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132: 105–11.

Marcelli D. , Stanhard D. , Conte F. , Held P.J. , Locatelli F. , Port F.K. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 1996; 50: 1013–18.

Maisonneuve P. , Agodoa L. , Gellert R. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93–9.

Adam H.O. , Chow W.H. , Nyren O. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996; 88: 1472–7.

Bruguera M. , Vidal L. , Sanchez-Tapias J. , Costa J. , Revert L. , Rodes J. Incidence and features of liver disease in patients on chronic hemodialysis. J Clin Gastroenterol 1990; 12: 298–302.

Chen K.S. , Lo S.K. , Lee N. , Leu M.L. , Huang C.C. , Fang K.M. Superinfection with hepatitis C virus in hemodialysis patients with hepatitis B surface antigenemia: its prevalence and clinical significance in Taiwan. Nephron 1996; 73: 158–64.

Sakai Y. , Izumi N. , Tazawa J. Characteristics of anti-HCV antibody positive patients with hepatocellular carcinoma on chronic hemodialysis: recommendation of periodic ultrasonography for early detection. Nephron 1996; 74: 386–9.

Gilli P. , Cavazzini L. , Stabellini N. , Malacarne N. , Soffritti S. , Storari A. Histological features of non-A, non-B hepatitis in hemodialysis patients. Nephron 1992; 61: 296–7.

Pol S. , Romeo R. , Zins B. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097–100.

Caramelo C. , Ortiz A. , Aguilera B. Liver disease patterns in hemodialysis patients with antibody to hepatitis C virus. Am J Kidney Dis 1993; 22: 822–8.

Alfurayh O. , Sobh M. , Buali A.R. Hepatitis C virus infection in chronic haemodialysis patients: a clinicopathological study. Nephrol Dial Transplant 1992; 7: 327–32.

Al-Wakeel J. , Malik G.H. , Al-Mohaya S. Liver disease in dialysis patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1996; 11: 2265–8.

Ozdogan M. , Ozgur O. , Gur G. Histopathological impacts of hepatitis virus infection in hemodialysis patients: should liver biopsy be performed before renal transplantation? Int J Artif Organs 1997; 21: 355–8.

Martin P. , Carter D. , Fabrizi F. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69: 1479–84.

Simon N. , Couroucè A.M. , Lemarrec N. , Trepo C. , Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994; 46: 504–11.

Stehman-Breen C.O. , Emerson S. , Gretch D. , Johnson R.J. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 629–34.

Nakayama E. , Akiba T. , Marumo F. , Sato C. Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11: 1896–902.

Gomez F. , Ruiz P. , Schreiver A. Impaired function of macrophage Fc receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994; 331: 112–28.

Goldblum S. , Red W. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980; 93: 597–613.

Knoll G.A. , Tankerseley M.R. , Lee J.Y. , Julian B.A. , Curtis J.J. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 1997; 29: 608–14.

Wolfe R.A. , Ashby V.B. , Milford E.L. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725–30.

Pereira B.J.G. , Natov S.N. , Bouthot B.A. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998; 53: 1374–81.

Evans A.S. Viral infections of humans, epidemiology and control. New York: Plenum, 1989.

Tiollais P. , Pourcel C. , Dejean A. The hepatitis B virus. Nature 1985; 317: 489–95.

Melnick J.L. In: Phillips L.A. ed. Virus associated with human cancer. New York: Dekker, 1983; 337.

Duesberg P.H. , Schwartz J.R. Latent viruses and mutated oncogenes: no evidence for pathogenicity. Progress Nucleic Acid Research and Molecular Biology 1992; 43: 135–204.

Duesberg P.H. Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Research 1987; 47: 1199–220.

Tsukuma H. , Hiyama T. , Tanaka S. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797–801.

Simonetti R.S. , Cammà C. , Fiorello F. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Int Med 1992; 116: 97–102.

Akano S. , Yokosuka O. , Imazeki F. , Tagawa M. , Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C. A prospective study of 251 patients. Hepatology 1995; 12: 671–5.

Ikeda K. , Saitoh S. , Koida I. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47–53.

Knew M.C. , Houghton M. , Choo Q.L. , Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 873–4.

Bruix J. , Calvet X. , Costa J. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 1004–6.

Colombo M. , Choo Q.L. , Del Ninno E. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006–8.

Yu M.C. , Tong M.J. , Coursaget P. , Ross R.K. , Govindarajan S. , Henderson B.E. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990; 82: 1038–41.

Beasley R.P. , Lin C.C. , Hwang L.Y. , Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22907 men in Taiwan. Lancet 1981; 2: 1129–32.

Mims C. , White D.O. Viral pathogenesis and immunology. Oxford: Blackwell, 1984.

Watson J.D. , Hopkins N.H. , Jeffrey W.R. , Steitz J.A. , Weiner A.M. Molecular biology of the gene. New York: Benjamin, 1987.

Rous P. The challenge to man of the neoplastic cell. Science 1967; 157: 24–8.